diabetes
Common diabetes drugs have been linked to a ‘flesh-eating’ genital infection
May 9, 2019Medical Communications, Research and Development FG, diabetes, gangrene, health, necrotizing fasciitis
Patients taking some newer diabetes medications – SGLT2 inhibitors – have been warned that they may be at risk of …
Diabetes drug may help people quit smoking
May 1, 2019Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation
A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …
Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients
April 29, 2019Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma
The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …
Janssen’s Invokana combo smashes primary and secondary endpoints in chronic kidney disease
April 16, 2019Manufacturing and Production, Research and Development Janssen, cardiovascular, chronic kidney disease, diabetes, invokana, pharma
Janssen has unveiled promising new Phase 3 for its sodium-glucose transport (SGLT) protein-2 inhibitor Invokana (canagliflozin), showing that the therapy …
Novo Nordisk’s oral semaglutide outclasses Januvia with new data in type 2 diabetes
March 26, 2019Manufacturing and Production, Research and Development Novo Nordisk, Ozempic, diabetes, pharma, type 2 diabetes
Novo Nordisk has revealed new dose-specific Phase 3a data for its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide, indicating that the …
Sanofi and Lexicon’s Zynquista denied type 1 diabetes approval by FDA complete response letter
March 25, 2019Sales and Marketing Zynquista. FDA, diabetes, pharma
Sanofi and Lexicon’s Zynquista (sotagliflozin) has hit a hurdle on its way to US approval for the treatment of type …
AZ’s diabetes drug Forxiga secures EU approval for adjunctive use in type 1 patients
March 25, 2019Sales and Marketing AstraZeneca, Forxiga, diabetes, pharma
AstraZeneca has revealed that its sodium-glucose co-transporter 2 (SGLT2) inhibitor Forxiga (dapagliflozin) has secured approval from the European Commission for …
23andMe to offer genetic reports on diabetes
March 11, 2019Sales and Marketing 23andME, Genentech, GlaxoSmithKline, Lundbeck, diabetes, genetics, genomics
Personal genomics company, 23andMe will offer customers information on the likelihood that they are genetically predisposed to developing type 2 …
Top Ten most popular articles on Pharmafile.com this week
February 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease
Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …
FDA to crack down on dietary supplements
February 12, 2019Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes
The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …
Insider Interview: The diabetes/mental health connection
December 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharma
Michael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …
Novo Nordisk’s semaglutide meets primary endpoint of reducing cardiovascular events at Phase 3
November 26, 2018Research and Development, Sales and Marketing Novo Nordisk, diabetes, pharma, semaglutide
Novo Nordisk has revealed new Phase 3a data for its investigational GLP-1 analogue therapy semaglutide, showing that the drug met …
3 in 4 UK diabetes patients suffer from mental health issues, says report
November 14, 2018Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma
To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …
NHS diabetes prescriptions top £1 billion a year
November 9, 2018Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma
The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …
Galectin-3: The protein paving new treatment avenues
November 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma
Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …
